Rocket Pharmaceuticals Secures Up To $150M Credit Facility

Rocket Pharmaceuticals has entered into a credit facility with Hercules Capital for up to $150 million, receiving $35 million at closing. The facility includes potential additional tranches tied to milestones and approvals, with an initial 30-month interest-only period and a 48-month maturity.